Quasar Aerospace Industries, Inc. (QASP: OTC Pink Current)

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Quasar Aerospace Industries, Inc. (QASP: OTC Pink Current) | Quasar Executes Terms of Acquisition Quasar Executes Terms of Acquisition

Quasar Executes Terms of Acquisition

JACKSONVILLE, FL--(Marketwired - Apr 23, 2014) - Quasar Aerospace Industries, Inc. (OTC Pink: QASP) ( PINKSHEETS : QASP ) ("Quasar" or "the Company")

Quasar Aerospace Industries, Inc.'s is thrilled to announce that it has entered into Terms of Acquisition with a premier Colorado hydroponic and scientific grow supply store. The hydroponic market is currently booming in Colorado and has the potential to spread throughout the country with little to no regulatory or legal limitations. One way to visualize this new step is to think of this opportunity as the pickaxe and pan seller during the "gold rush." Quasar will provide the hydroponic grow supplies necessary for the growth and production for the "green rush." 

This hydroponic grow store is complete with a full inventory as well as delivery vans and other tangible assets. Not only is the store fully stocked but also prepped to immediately open a second facility. This store represents copious amounts of distributors which allows them to carry thousand of products for all types of growing and high-tech gardening needs. The store also currently contracts with numerous medical and recreational dispensaries throughout the State of Colorado and operates seven days a week. In the first quarter alone this store has generated nearly a million dollars in revenues. 

This is only the beginning of the great opportunities and revenues to be realized by Quasar. Once the acquisition is finalized in the very near future a second location will be opened. The expansion of store fronts will be rapid and will include a future location in Florida as well as other target locations throughout the country wherein Quasar will be a front runner in being prepared for the new MMJ/MJ market to hit each state. Since this type of store has little to no regulations or laws hindering its ability to expand into states wherein MJ or MMJ is not currently legal it can capture the market prior to the legal authorization for the industry to enter each state. Once the laws are past we will be the store that is up and running and ready to supply and service dispensaries and individuals with their growth needs allowing us to immediately capture the market and revenues to be generated in this industry. 

Quasar's President Donnell J. Vigil states, "Hydroponically grown produce typically consists of premium products therefore this industry is able to charge high prices for quality hydroponic systems. As a direct result, a steady increase in the industries profit margins has been realized over the past five years as demand has accelerated. With the growing prevalence of medical marijuana and marijuana legalization in certain states this has fueled rising interest in hydroponic growing methods and more marijuana will need to be produced to keep up with the demand. Furthermore, with Colorado's legalized recreational marijuana consumption this creates a new market for marijuana cultivation which Quasar will ensure to capitalize on."

Quasar has established a Colorado subsidiary, Green Energy Investments, Inc. as a holding company for upcoming projects in the MJ/MMJ industry. The acquisition of this hydroponic grow store is just the first part of a large plan. In the future there will be cultivation centers, warehouses, edibles, and real estate all of which are currently being pursued. This store will provide the first portion of the necessary tools and knowledge to effectively develop and service not only one dispensary but numerous dispensaries at the same time through its future cultivation centers. There are dispensaries in Colorado that have already indicated that are ready to participate in a cultivation center upon establishment. 

Quasar is excited to unleash its branding into the marketplace. The growth store actively markets this brand and Quasar intends to take it nationwide. Unfortunately, due to harassing and unpleasant contact by bashers, Quasar is holding on releasing the name until closing as to not obstruct this deal in any manner. 

Please feel free to contact Quasar by telephone or email at donnell@quasaraerospaceindustries.com for information or investment opportunities. Quasar will continue to update our shareholders and the investment community as progress and details are ready to be released.

Quasar and its subsidiaries are involved in aviation and aviation related businesses. We are SEVIS/SEVP certified to provide training to foreign students. We are the only certified Cessna Pilot Center ( http://www.cessna.com/learn-to-fly.html ) in Jacksonville, FL. Through our subsidiaries we are an FAA Part 141 flight school ( www.faa.gov ), Computer Assisted Testing Service (CATS) ( http://www.catstest.com ) and a Comira testing facility ( http://www.comiratesting.com ). We offer flight training and accept VA benefits under the GI bill ( http://www.gibill.va.gov/ ). Atlantic Aviation, Inc. is a recipient of an AOPA Excellence Award for 2012 and recognized as one of the top 50 flight school in the country. ( http://flighttraining.aopa.org/awardwinners/2012winners.html ).

SEVIS ( http://studyinthestates.dhs.gov/assets/images...3-5-14.pdf ) ( http://www.ice.gov/sevis/ ) 

Check us out on our web site ( www.quasaraero.com ) and Facebook at: http://www.facebook.com/pages/Quasar-Aerospac...4125485747 or look to schedule a student pilot experience flight through Groupon ( www.groupon.com ) or Living Social ( www.livingsocial.com ).

This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements as a result of various factors, and other risks. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and Quasar Aerospace Industries, Inc. under take no obligation to update such statements.

Contact
Quasar Aerospace Industries, Inc.
Telephone: (904) 207-6503
Email: donnell@quasaraerospaceindustries.com
Website: www.quasaraero.com
Facebook: http://www.facebook.com/pages/Quasar-Aerospac...4125485747

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 87

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 399

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 448

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 72

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 0

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
Ascletis' Preclinical Successes: Future of Obesity Treatment

Updated Category News Views 14

Pharma Giants Eyeing a New Potential Well, it seems the world of pharma is buzzing with Ascletis’ latest developments in the obesity treatment arena. They’ve just showcased some intriguing preclinical data at ObesityWeek® 2026. The standout? A cocktail of advancements that might just put a dent in the obesity epidemic if further studies pan out. ASC30_48: A Daily...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 412

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 89

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 284

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 115

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading

Top 5 Most Recently Viewed Articles

O-I Glass Announces Participation in Citi’s 2025 Conference

Updated Category News Views 208

O-I Glass Participation in the 2025 Basic Materials Conference PERRYSBURG, Ohio — O-I Glass, Inc., known for its commitment to creating exceptional glass products, is set to participate in the upcoming Citi’s 2025 Basic Materials Conference. This significant event will take place on a Wednesday in December, and features notable presentations from O-I's leadership....

Continue Reading
Osmium Partners Proposes Strategic Plan for Articore Growth

Updated Category News Views 104

Osmium Partners Proposes a Four-Step Plan for Articore Osmium Partners has recently made headlines with their proposal for Articore, aiming to elevate shareholder value through a methodical four-step approach. This initiative is driven by Osmium's belief that Articore's current management strategy lacks direction and has resulted in missed opportunities for growth and...

Continue Reading
Amplify Energy Set to Shine at EnerCom Denver Conference 2025

Updated Category News Views 135

Amplify Energy’s Participation in EnerCom Denver Conference Amplify Energy Corp. is gearing up to participate in the renowned annual EnerCom Denver Conference in 2025. This event, known for bringing together leading experts and investors in the energy sector, offers Amplify a prime platform to showcase its strategic initiatives and growth potential. Focus on Investor...

Continue Reading
Safe Life Expands CPR Training and AED Services through Acquisition

Updated Category News Views 197

Safe Life Strengthens National Coverage for Life-Saving Training Safe Life has made a significant move by acquiring HeartCert, a company known for its specialization in automated external defibrillators (AEDs) and CPR training. This acquisition allows Safe Life to broaden its reach into the Midwest, enhancing its commitment to providing life-saving training and equipment...

Continue Reading
Express Scripts Challenges FTC's Drug Pricing Conclusions

Updated Category News Views 106

Express Scripts Files Lawsuit Against the FTC Express Scripts, a major player in the pharmacy benefit manager sector, has recently taken legal action against the U.S. Federal Trade Commission (FTC). This lawsuit stems from a report that criticizes the role of pharmacy benefit managers in the pricing of medications. Express Scripts contends that the report's conclusions...

Continue Reading